LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 103 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.08 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34 | -48.5% | 30,937 | +7.4% | 0.00% | – |
| Q2 2023 | $66 | +15.8% | 28,815 | +23.9% | 0.00% | – |
| Q1 2023 | $57 | +29.5% | 23,255 | +1.7% | 0.00% | – |
| Q4 2022 | $44 | -99.9% | 22,866 | -5.1% | 0.00% | – |
| Q3 2022 | $58,000 | +123.1% | 24,096 | +94.4% | 0.00% | – |
| Q1 2022 | $26,000 | -39.5% | 12,393 | +13.7% | 0.00% | – |
| Q4 2021 | $43,000 | -52.2% | 10,901 | +4.0% | 0.00% | -100.0% |
| Q1 2018 | $90,000 | -44.1% | 10,479 | -35.6% | 0.00% | 0.0% |
| Q4 2017 | $161,000 | +73.1% | 16,261 | +151.4% | 0.00% | 0.0% |
| Q2 2016 | $93,000 | +55.0% | 6,469 | +29.2% | 0.00% | – |
| Q1 2016 | $60,000 | +17.6% | 5,006 | +30.9% | 0.00% | – |
| Q4 2015 | $51,000 | -7.3% | 3,824 | -25.0% | 0.00% | – |
| Q3 2015 | $55,000 | +323.1% | 5,096 | +220.9% | 0.00% | – |
| Q2 2015 | $13,000 | – | 1,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |